This report is FREE today only!
Acorda Therapeutics (ACOR) Stock Quotes & Symbols
Get Expert Advice & Free Trading Report for ACOR
Report Preview
I Answer Questions
via 1-1 Live Chat
- Trading Plans for ACOR
- Stock Traders Daily
- Multi Tiered Analysis
- Free
- Unbiased long/short strategies
- Adobe Acrobat®
- Included
- Also available for $18 through Reuters
Report Details
Empower Your Competitive Advantage.
Acorda Therapeutics (ACOR) Stock Quote Price Graph
Acorda Therapeutics (ACOR) Stock Quote Information
Acorda Therapeutics, Inc., a biotechnology company, develops therapies for multiple sclerosis, spinal cord injury, and other nervous system disorders. Its marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with multiple sclerosis; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity. The company?s pipeline also includes various products in development for the treatment, regeneration, and repair of the spinal cord and brain. Its preclinical products comprise remyelination programs that include two distinct therapeutic approaches to stimulate repair of the damaged myelin sheath in multiple sclerosis, neuregulins/glial growth factor 2, and remyelinating antibodies; and chondroitinase program, which develops second generation approaches to overcoming the proteoglycan matrix. Acorda Therapeutics sells its products through specialty sales force, managed care team, and contract pharmaceutical telesales organizations. The company was founded in 1995 and is based in Hawthorne, New York.
Buy and Hold is Dead
10 Day Free Trial Offer
Here are a few of the services we offer. Sign up for a Free Trial to find out more.
The Investment Rate is the most accurate leading longer term stock market and economic indicator ever developed. It is the foundation of everything we do. The IR measures the rate of change in the amount of new money available for investment into our economy every year, and for extended periods of time. If has predicted the Great Depression, the Stagflation Period of the 1970s, and the up-periods in between. It impacts all asset classes: stocks, real estate, private business, and any other asset class that relies on new money to grow. Use it to make investment decisions and business decisions. The accuracy is unparalleled. Find out what it says about the immediate future by signing up for a free trial, and see if your decisions line up with the most accurate leading economic indicator in history.
Most money managers do not control risk. They get paid to invest money, not to move it to cash. You must control your own risk; you have to. This is not an option. However, it does not have to be complicated either. Our services are designed to make the transition to risk control seamless. We all know we should do it, now anyone can do it. All of our strategies are focused on risk control and wealth preservation. Performance is a natural byproduct. Stop chasing performance, and start chasing risk control. You will be happier, and better off. Sign up for a free trial to see how our services can make risk control and opportunity paradigm for you too.
A revolution in rule based trading. Trend Tracker is an
automated - correlated market timing and stock selection tool
that allows normal people, with normal jobs, to control their
risk and realize opportunities regardless of economic conditions
or market direction, and without sacrificing time or lifestyle.
Work, play golf, or trade other stocks, and feel confident that
your wealth is being protected and that you are positioning
yourself to profit when opportunities arise.
Sign up for a free trial to learn more.
We offer trading reports on 1300 different companies through Reuters.